人冠状病毒NL63受体结合区蛋白的原核表达纯化与鉴定  

Prokaryotic Expression and Characterization of Two Recombinant Receptor-binding Domain(RBD) Proteins of Human Coronavirus NL63(HCoV-NL63)

作　　者：常慧[1,2] 伊瑶[2] 赵敏[2,3] 周为民[2] 赵国霞[2,3] 王慧娟[2] 毕胜利[2] 高基民[3] 刘冰[1] 谭文杰[2,3] 

机构地区：[1]吉林大学白求恩医学院遗传学系,长春130021 [2]中国疾病预防控制中心病毒病预防控制所,北京102206 [3]温州医学院医学病毒学研究所,温州325000

出　　处：《病毒学报》2013年第2期106-111,共6页Chinese Journal of Virology

基　　金：国家863课题(2007AA02Z464);传染病重大专项(2008ZX10004-014)

摘　　要：人冠状病毒NL63受体结合区蛋白是其免疫学诊断和疫苗研究的主要靶点,在受体吸附、病毒进入细胞及膜融合中起关键作用。本研究在E.coli系统中进行人冠状病毒NL63受体结合区(RBD)大、小蛋白的表达纯化,并对其进行免疫学鉴定。首先密码子优化设计合成了HCoV-NL63的RBD大片段(RL:232-684aa)与小片段(RS:476-616aa)的编码基因,并将其克隆进硫氧还蛋白表达载体pM48,构建了人冠状病毒NL63的受体结合区蛋白(RBD)大(RL)、小(RS)片段与硫氧还蛋白的融合表达质粒;转化E.coli BL21pLys S,利用IPTG进行诱导表达,用镍亲和层析对蛋白进行纯化,并以表达HCoV-NL63RL与RS蛋白的重组痘苗病毒免疫小鼠血清对重组蛋白进行免疫印迹鉴定。结果表明在37℃,0.8mM IPTG诱导4h时,蛋白表达量达到最高,融合蛋白主要以包涵体形式表达,纯化后纯度可达95%以上。Western blot显示,两个融合蛋白均与痘苗病毒(天坛株)表达的HCoV-NL63RL与RS蛋白免疫的小鼠血清发生特异性反应。本研究首次在国内用原核系统表达纯化并鉴定了人冠状病毒NL63受体结合区大小蛋白(RL和RS),为人冠状病毒NL63感染的免疫学检测与疫苗研究提供了基础。The receptor-binding domain（RBD） protein of HCoV-NL63 is a major target in the development of diagnostic assay and vaccine, it has a pivotal role in receptor attachment, viral entry and membrane fusion. In this study, we prepared 2 purified recombinant HCoV-NL63 RBD proteins using in E. coli system and identified the proteins by Western blotting. We first optimized codon and synthesized the RL （232-684aa）coding gene, then amplified the RL or RS（476-616aa） coding gene via PCR using different primers . The RL or RS coding gene was cloned into the pM48 expression vector fused with TrxA tag. The RBD （RL and RS） of HCoV-NL63 were expressed majorly as inclusion body when expressed in E. coli BL21pLys S under different conditions. The expressed products were purified by affinity chromatography then analyzed by SDS-PAGE and Western blotting. Our results showed that the recombinant RBD proteins were maximally expressed at 37;Cwith 0.8raM IPTG induction for 4h. RL or RS protein with 95; purity was obtained and reacted positively with anti-sera from mice immunized with the recombinant vaccinia virus （Tiantan strain） in which HCoV-NL63 RL or RS protein was expressed. In conclusion, the purified recombinant RBD proteins（RL and RS）derived from E. coli were first prepared in China and they might provide a basis for further exploring biological role and vaccine development of HCoV-NL63.

关 键 词：HCoV NL63 受体结合区蛋白 重组蛋白 表达 大肠杆菌 

分 类 号：R373.1[医药卫生—病原生物学]